10-Q: Quarterly report [Sections 13 or 15(d)]
Published on
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
or
For the transition period from _________ to _________
Commission file number
(Exact Name of Registrant as Specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, Zip Code)
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered under Section 12(g) of the Act: Subordinate Voting Shares, no par value
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| ☒ | Smaller Reporting Company | ||
| Emerging Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
As of November 13, 2026, the registrant had Subordinate Voting Shares and 0 Multiple Voting Shares outstanding.
TABLE OF CONTENTS
i
PART I – FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

GROWN ROGUE INTERNATIONAL INC.
Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2026 and 2025
Expressed in United States Dollars
(Unaudited)
1
Grown Rogue International Inc.
Condensed Consolidated Balance Sheets
As at September 30, 2026 and December 31, 2025
(Expressed in United States Dollars) - Unaudited
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Accounts receivable, net (Note 5) | ||||||||
| Inventory (Note 6) | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Derivative asset (Note 13) | ||||||||
| Current portion of notes receivable (Note 9) | ||||||||
| Total current assets | ||||||||
| Other long-term assets | ||||||||
| Warrants asset (Note 7) | ||||||||
| Other investments (Note 8) | ||||||||
| Notes receivable (Note 9) | ||||||||
| Lease receivable | ||||||||
| Property and equipment, net (Note 10) | ||||||||
| Right of use assets, operating leases (Note 11) | ||||||||
| Right of use assets, finance leases (Note 11) | ||||||||
| Deferred tax asset | ||||||||
| Intangible assets | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES | ||||||||
| Current liabilities | ||||||||
| Accounts payable and accrued liabilities | ||||||||
| Current portion of operating lease liabilities (Note 11) | ||||||||
| Current portion of finance lease liabilities (Note 11) | ||||||||
| Current portion of long-term debt (Note 12) | ||||||||
| Current portion of business acquisition consideration payable | ||||||||
| Derivative liability (Note 13) | ||||||||
| Warrant liabilities (Note 13) | ||||||||
| Income tax payable | ||||||||
| Total current liabilities | ||||||||
| Operating lease liabilities (Note 11) | ||||||||
| Finance lease liabilities (Note 11) | ||||||||
| Long-term debt (Note 12) | ||||||||
| Business acquisition consideration payable | ||||||||
| Other non-current liabilities (Note 18) | ||||||||
| Total liabilities | ||||||||
| Commitments and contingencies (Note 24) | ||||||||
| Redeemable non-controlling interest (Note 23) | ||||||||
| SHAREHOLDERS’ EQUITY | ||||||||
| Subordinate voting common shares, convertible into multiple voting common shares, par value; unlimited shares authorized; and shares issued and outstanding as at September 30, 2026 and December 31, 2025, respectively | ||||||||
| Multiple voting common shares, par value; unlimited shares authorized; nil and nil shares issued and outstanding as at September 30, 2026 and December 31, 2025, respectively | ||||||||
| Accumulated other comprehensive loss | ( |
) | ( |
) | ||||
| Accumulated deficit | ( |
) | ( |
) | ||||
| Equity attributable to shareholders | ||||||||
| Non-controlling interests (Note 23) | ||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||
| TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY | ||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
2
Grown Rogue International Inc.
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)
For the three and nine months ended September 30, 2026 and 2025
(Expressed in United States Dollars, except share amounts) - Unaudited
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| $ | $ | $ | $ | |||||||||||||
| Revenue | ||||||||||||||||
| Product sales | ||||||||||||||||
| Total revenue | ||||||||||||||||
| Cost of goods sold | ||||||||||||||||
| Cost of finished cannabis inventory sold | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Total cost of goods sold | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Gross profit | ||||||||||||||||
| Operating expenses | ||||||||||||||||
| Depreciation (Notes 10, 11) | ||||||||||||||||
| General and administrative | ||||||||||||||||
| Share-based compensation (Note 16) | ||||||||||||||||
| Total operating expenses | ||||||||||||||||
| Income (loss) from operations | ( |
) | ( |
) | ||||||||||||
| Other income (expense) | ||||||||||||||||
| Interest and accretion expense (Notes 12, 13) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Other income (expense) | ||||||||||||||||
| Interest income (Note 9) | ||||||||||||||||
| Unrealized gain (loss) on derivative liability (Note 13) | ( |
) | ( |
) | ||||||||||||
| Realized gain on derivative liability (Note 13) | ||||||||||||||||
| Unrealized gain (loss) on warrant asset (Note 7) | ( |
) | ( |
) | ||||||||||||
| Unrealized gain (loss) on warrant liability (Note 13) | ( |
) | ||||||||||||||
| Loss on acquisition of Rogue EBC (Note 4) | ( |
) | ( |
) | ||||||||||||
| Loss on equity investment in associate (Note 8) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Total other income (expense), net | ( |
) | ( |
) | ||||||||||||
| Income (loss) before income tax expense | ( |
) | ( |
) | ||||||||||||
| Income tax expense (Note 18) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Net income (loss) | ( |
) | ( |
) | ||||||||||||
| Other comprehensive income (loss) | ||||||||||||||||
| Currency translation adjustment | ||||||||||||||||
| Total comprehensive income (loss) | ( |
) | ( |
) | ||||||||||||
| Basic income (loss) per share | ( |
) | ( |
) | ||||||||||||
| Basic weighted average number of subordinate voting common shares outstanding (Note 17) | ||||||||||||||||
| Diluted income (loss) per share | ( |
) | ( |
) | ||||||||||||
| Diluted weighted average number of subordinate voting common shares outstanding (Note 17) | ||||||||||||||||
| Net income (loss) for the period attributable to: | ||||||||||||||||
| Shareholders | ( |
) | ( |
) | ||||||||||||
| Non-controlling interests | ||||||||||||||||
| Redeemable non-controlling interest (Note 23) | ( |
) | ( |
) | ||||||||||||
| Net income (loss) | ( |
) | ( |
) | ||||||||||||
| Total comprehensive income (loss) for the period attributable to: | ||||||||||||||||
| Shareholders | ( |
) | ( |
) | ||||||||||||
| Non-controlling interests | ||||||||||||||||
| Redeemable non-controlling interest (Note 23) | ( |
) | ( |
) | ||||||||||||
| Total comprehensive income (loss) | ( |
) | ( |
) | ||||||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
3
Grown Rogue International Inc.
Condensed Consolidated Statements of Changes in Shareholders’ Equity
For the three and nine months ended September 30, 2026 and 2025
(Expressed in United States Dollars, except share amounts) - Unaudited
| Subordinate voting common shares |
Paid in capital |
Accumulated other loss |
Accumulated deficit |
Non-controlling interests |
Total shareholders’ |
|||||||||||||||||||
| # | $ | $ | $ | $ | $ | |||||||||||||||||||
| Balance - December 31, 2024 | ( |
) | ( |
) | ||||||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||||||
| Settlement of July Convertible Debentures | ||||||||||||||||||||||||
| Settlement of restricted share units | ||||||||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Currency translation adjustment | - | |||||||||||||||||||||||
| Net income | - | |||||||||||||||||||||||
| Balance - March 31, 2025 | ( |
) | ( |
) | ||||||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||||||
| Settlement of July Convertible Debentures | ||||||||||||||||||||||||
| Dividend issued from Golden Harvests, LLC to minority owner | - | ( |
) | ( |
) | |||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Currency translation adjustment | - | ( |
) | ( |
) | |||||||||||||||||||
| Net income | - | |||||||||||||||||||||||
| Balance - June 30, 2025 | ( |
) | ( |
) | ||||||||||||||||||||
| Settlement of restricted share units | ||||||||||||||||||||||||
| Dividend issued from Golden Harvests, LLC to minority owner | - | ( |
) | ( |
) | |||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Currency translation adjustment | - | |||||||||||||||||||||||
| Net income | - | |||||||||||||||||||||||
| Balance - September 30, 2025 | ( |
) | ( |
) | ||||||||||||||||||||
| Balance - December 31, 2025 | ( |
) | ( |
) | ||||||||||||||||||||
| Sale of non-controlling interest in GRMA | - | |||||||||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||||||
| Dividends to non-controlling interests in subsidiaries | - | ( |
) | ( |
) | |||||||||||||||||||
| Reclassification of warrants | - | ( |
) | ( |
) | |||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Net income (loss) | - | ( |
) | ( |
) | |||||||||||||||||||
| Balance - March 31, 2026 | ( |
) | ( |
) | ||||||||||||||||||||
| Dividends to non-controlling interests in subsidiaries | - | ( |
) | ( |
) | |||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Net income (loss) | - | ( |
) | ( |
) | |||||||||||||||||||
| Balance - June 30, 2026 | ( |
) | ( |
) | ||||||||||||||||||||
| SV Shares to be issued for debt facility commitment fee | - | |||||||||||||||||||||||
| Dividends to non-controlling interests in subsidiaries | - | ( |
) | ( |
) | |||||||||||||||||||
| Share-based compensation expense | - | |||||||||||||||||||||||
| Net income (loss) | - | ( |
) | ( |
) | |||||||||||||||||||
| Balance - September 30, 2026 | ( |
) | ( |
) | ||||||||||||||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
4
Grown Rogue International Inc.
Condensed Consolidated Statements of Cash Flows
For the nine months ended September 30, 2026 and 2025
(Expressed in United States Dollars, unless otherwise indicated) - Unaudited
| Nine months ended September 30 |
||||||||
| 2026 | 2025 | |||||||
| $ | $ | |||||||
| Operating activities | ||||||||
| Net income (loss) | ( |
) | ||||||
| Adjustments for non-cash items in net income (loss): | ||||||||
| Depreciation of property and equipment | ||||||||
| Depreciation of property and equipment included in costs of finished cannabis inventory sold | ||||||||
| Lease costs included in costs of finished cannabis inventory sold | ||||||||
| Share-based compensation | ||||||||
| Interest and accretion expense | ||||||||
| Other income | ( |
) | ||||||
| Interest income | ( |
) | ( |
) | ||||
| Unrealized (gain) loss on derivative liability | ( |
) | ||||||
| Realized gain on derivative liability | ( |
) | ||||||
| Unrealized (gain) loss on warrant asset | ( |
) | ||||||
| Unrealized gain on warrant liability | ( |
) | ||||||
| Loss on acquisition of Rogue EBC | ||||||||
| Loss on equity investment in associate | ||||||||
| Deferred income taxes | ( |
) | ( |
) | ||||
| Proceeds from tenant improvement allowance | ||||||||
| Changes in operating assets and liabilities (Note 19) | ( |
) | ||||||
| Net cash provided by (used in) operating activities | ( |
) | ||||||
| Investing activities | ||||||||
| Purchase of property and equipment | ( |
) | ( |
) | ||||
| Payments of business acquisition consideration payable | ( |
) | ( |
) | ||||
| Advance of notes receivable | ( |
) | ||||||
| Advance of security deposit | ( |
) | ||||||
| Cash acquired on purchase of remaining Rogue EBC, LLC equity interest | ||||||||
| Advance on purchase of remaining Rogue EBC, LLC equity interest | ( |
) | ( |
) | ||||
| Deposit paid toward proposed acquisition (Note 25) | ( |
) | ||||||
| Net cash used in investing activities | ( |
) | ( |
) | ||||
| Financing activities | ||||||||
| Proceeds from issuance of GRNY preferred units | ||||||||
| Sale of non-controlling interest in GRMA, net of issuance costs | ||||||||
| Dividends to non-controlling interests from subsidiaries | ( |
) | ( |
) | ||||
| Proceeds from long-term debt | ||||||||
| Debt issuance costs | ( |
) | ||||||
| Repayment of long-term debt | ( |
) | ( |
) | ||||
| Repayment of finance lease | ( |
) | ( |
) | ||||
| Proceeds from exercise of stock options | ||||||||
| Net cash provided by financing activities | ||||||||
| Effect of foreign exchange on cash and cash equivalents | ||||||||
| Change in cash and cash equivalents | ||||||||
| Cash and cash equivalents, beginning of period | ||||||||
| Cash and cash equivalents, ending of period | ||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
5
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 1. | NATURE OF THE ORGANIZATION AND BUSINESS |
Grown Rogue International Inc. (the “Company”) was incorporated under the Business Corporations Act (Ontario) on November 1, 2018. The primary cannabis product produced and sold is cannabis flower. The registered office is located at 40 King St W Suite 5800, Toronto, ON M5H 3S1.
The Company is a cannabis operator in Oregon, Michigan, New Jersey and with operations being provisioned in Illinois, New York and Minnesota, USA and is engaged in the cultivation of and manufacturing of cannabis flower and extract products for wholesale and retail sales.
At the federal level, cannabis sold under state adult-use programs remains a Schedule I controlled substance. In April 2026, marijuana produced and sold under state medical licenses was rescheduled to Schedule III. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of accepted safety for the use of the drug under medical supervision. As such, even in those states in which marijuana is legalized under state law, the manufacture, importation, possession, use or distribution of cannabis remains illegal under U.S. federal law. This has created a dichotomy between state and federal law, whereby many states have elected to regulate and remove state-level penalties regarding a substance which is still illegal at the federal level. There remains uncertainty about the US federal government’s position on cannabis with respect to cannabis-legal status. A change in its enforcement policies could have a material adverse effect on the Company’s business, results of operations and financial condition.
| 2. | BASIS OF PRESENTATION |
These unaudited condensed interim consolidated financial statements should be read in conjunction with the audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC. The condensed consolidated balance sheet as at December 31, 2025 was derived from the audited consolidated financial statements but does not include all of the disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, all adjustments considered necessary for a fair statement of the results for the interim periods have been made. All such adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2026, are not necessarily indicative of the results to be expected for the full fiscal year.
During 2025, the Company determined that more than 50% of its outstanding common shares were held by U.S. stockholders and, as a result, no longer met the definition of a foreign private issuer under U.S. securities laws. Accordingly, commencing with the year ended December 31, 2025, the Company is required to present its financial statements in accordance with U.S. GAAP rather than IFRS® Accounting Standards as issued by the International Accounting Standards Board.
The Company has prepared audited consolidated financial statements in accordance with U.S. GAAP for the year ended December 31, 2025. These condensed consolidated financial statements and the accompanying note disclosures have been prepared on a basis consistent with the Company’s audited consolidated financial statements and reflect only those adjustments necessary, in the opinion of management, for fair statement of the results for the interim periods.
6
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 2. | BASIS OF PRESENTATION (continued) |
| 2.1 | Functional and presentation currency |
The Company’s reporting currency is the United States Dollar (“USD”). Effective January 1, 2026, the Company changed its functional currency from the Canadian Dollar (“CAD”) to the USD based on management’s determination that the USD had become the Company’s primary economic environment due to changes in underlying transactions, events, and operating conditions. All subsidiaries have a functional currency of USD.
The change in functional currency was applied prospectively from January 1, 2026 in accordance with ASC 830, Foreign Currency Matters. Translated amounts of non-monetary assets and liabilities at December 31, 2025 became the historical accounting basis for those assets and liabilities at January 1, 2026. The cumulative translation adjustment recognized in accumulated other comprehensive loss prior to the change has not been reversed and continues to be reported in equity.
For the comparative period (nine months ended September 30, 2025), when the Company’s functional currency was CAD, assets and liabilities were translated to USD at exchange rates prevailing at the end of the reporting period, and income and expense items were translated at the average exchange rates for the period. Exchange differences arising from translation were recognized in other comprehensive income (loss) and reported as currency translation reserve in shareholders’ equity.
| 2.2 | Use of estimates |
The preparation of the Company’s financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of certain assets, liabilities, and expenses as well as the related disclosures. The Company must often make estimates about effects of matters that are inherently uncertain and will likely change in subsequent periods. Actual results could differ materially from those estimates.
Areas requiring a significant degree of estimation and judgment relate to the assessment of transactions as business combinations or asset acquisitions, estimates used in valuation and costing of inventory, impairment of long-lived assets and indefinite lived intangible assets, fair value measurements, the recoverability and measurement of deferred tax assets and liabilities, share-based compensation, fair value of derivative assets and liabilities, and consolidation of entities in which the Company holds less than a majority of voting rights.
| 2.3 | Basis of consolidation |
These financial statements incorporate the accounts of the Company and all the entities in which the Company has a controlling voting interest and is deemed to be the primary beneficiary. All consolidated entities were under common control during the entirety of the periods for which their respective results of operations were included in the consolidated statements from the date of acquisition. All intercompany balances and transactions are eliminated upon consolidation.
7
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 2. | BASIS OF PRESENTATION (continued) |
A summary of the Company’s subsidiaries included in these financial statements as at September 30, 2026 is as follows:
| Entity | Defined term | Location | Purpose | Percentage held |
||||||
| % | ||||||||||
| % | ||||||||||
| % | ||||||||||
| % | ||||||||||
| % | ||||||||||
| %* | ||||||||||
| %** | ||||||||||
| % | ||||||||||
| % | ||||||||||
| %*** | ||||||||||
| % | ||||||||||
| % | ||||||||||
| %**** | ||||||||||
| %***** | ||||||||||
| * | |
| ** | |
| *** | |
| **** | |
| ***** |
All subsidiaries of the Company were incorporated in the United States of America and have USD as their functional currency.
8
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 2. | BASIS OF PRESENTATION (continued) |
| 2.4 | Reclassifications |
As at December 31, 2025, finance lease right-of-use assets with a historical cost of $337,336 and accumulated amortization of $110,205 were included within property and equipment, net. During the nine months ended September 30, 2026, the Company reclassified these balances to right of use assets, finance leases on the condensed consolidated balance sheet to conform to the current presentation and to improve comparability.
The initial draw of the Fridley, Minnesota tenant improvement allowance (Note 11), presented within long-term debt at June 30, 2026, is presented within operating lease liabilities at September 30, 2026.
| 3. | SIGNIFICANT ACCOUNTING POLICIES |
The accounting policies used in the preparation of these financial statements are consistent with those described in the Company’s audited consolidated financial statements for the year ended December 31, 2025. Material accounting policies applied in these condensed consolidated financial statements as follows:
Revenue
Revenue is recognized in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”) when goods or services are transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.
In order to recognize revenue under ASC 606, the Company applies the following five steps:
| 1. | Identify a customer along with a corresponding contract |
| 2. | Identify the performance obligation(s) in the contract to transfer goods or provide distinct services to a customer |
| 3. | Determine the transaction price that the Company expects to be entitled to in exchange for transferring promised goods or services to a customer |
| 4. | Allocate the transaction price to the performance obligation(s) in the contract |
| 5. | Recognize revenue when or as the Company satisfies the performance obligation(s) in the contract |
Revenue from the sale of goods is generally recognized when control over the goods has been transferred to the customer. Payment for sales is typically due prior to shipment. The Company has elected to treat shipping and handling activities as a fulfillment activity, meaning these activities are not considered a separate performance obligation. Shipping and handling fees billed to customers are recognized as revenue at the time control of the goods passes to the customer. Costs incurred by the Company for shipping and handling are classified as cost of sales in the consolidated statements of income (loss) and comprehensive income (loss). Payment for wholesale transactions is due within a specified time period as permitted by the underlying agreement and the Company’s credit policy upon the transfer of goods to the customer. The Company generally satisfies its performance obligation and transfers control to the customer upon delivery and acceptance by the customer. Revenue is recorded at the estimated amount of consideration to which the Company expects to be entitled.
9
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 3. | SIGNIFICANT ACCOUNTING POLICIES (continued) |
Inventory
Inventory consists of (i) raw materials, consumables and packaging supplies used in the process to prepare inventory for sale, (ii) work in process consisting of pre-harvested cannabis plants, and (iii) finished goods.
Inventory is valued at the lower of cost and net realizable value, with cost determined using the weighted average cost method. Net realizable value is calculated as the estimated selling price in the ordinary course of business, less any estimated costs to complete and sell the goods. Costs are capitalized to inventory, until substantially ready for sale. Costs include direct and indirect labor, raw materials, consumables, packaging supplies, utilities, facility costs, quality and testing costs, production related depreciation and other overhead costs including operating lease costs.
The Company records inventory reserves for obsolete and slow-moving inventory. Inventory reserves are based on inventory obsolescence trends, and the historical and professional experience of management. The Company classifies cannabis inventory as a current asset, although, due to the duration of the cultivation, drying, and conversion process, certain inventory items may not be realized in cost of sales within one year.
Financial instruments
Financial instruments are contracts that give rise to a financial asset of one party and a financial liability or equity instrument of another party. Financial instruments are recorded initially at fair value, which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Subsequent measurement depends on how the financial instrument has been classified and may be at fair value or amortized cost. For financial instruments subsequently measured at fair value, the Company calculates the estimated fair value of financial instruments using quoted market prices whenever available. When quoted market prices are not available, the Company uses standard pricing models including the Black-Scholes option pricing model.
Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Inputs other than quoted prices that are observable for the asset or liability either directly (i.e. as prices) or indirectly (i.e. derived from prices); and
Level 3 - Inputs that are not based on observable market data.
There have been no transfers between fair value hierarchy levels during the three and nine months ended September 30, 2026 and 2025.
The Company’s cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities are recorded at cost. The carrying values of these financial instruments approximate their fair value due to their short-term maturities. The Company’s note receivable, long-term debt, business acquisition consideration payable, and convertible debentures are valued at amortized cost using the effective interest rate method. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest risks arising from these financial instruments. The Company’s warrants asset and warrant liabilities are measured using the Black-Scholes option pricing model, and its interest rate swaps are measured using a discounted cash flow model (Notes 7 and 13).
10
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 3. | SIGNIFICANT ACCOUNTING POLICIES (continued) |
Share-based compensation expense consists of the Company’s stock option and restricted share unit expense.
Stock options and restricted share units granted to employees and consultants are measured based on the grant-date fair value. Share-based compensation expense for stock options is generally recognized based on the straight-line basis over the requisite service period. The Company has elected to account for forfeitures of share-based awards as they occur rather than estimating forfeitures at the grant date. Accordingly, stock-based compensation expense is recognized assuming all awards will vest, and previously recognized compensation cost is reversed in the period in which an award is forfeited due to an employee’s failure to satisfy the applicable service conditions.
Share-based compensation for restricted share units is measured at grant-date fair value, determined by multiplying the share price on the date of grant by the number of restricted share units granted, and is recognized over the requisite service period. Share-based compensation expense is included in share-based compensation expense or cost of finished cannabis inventory sold based on the employee’s function classification.
Consideration paid to the Company on the exercise of stock options is recorded as subordinate voting common shares (“SV Shares”).
Non-controlling interests
Net income or loss of non-wholly owned subsidiaries is attributed to non-controlling interests based on their ownership interests, except for GRMA and GRNY. Holders of the GRMA Units (Note 23) are entitled to a cumulative, non-compounded preferred return of 15% per annum on unreturned capital contributions, and net income attributed to the non-controlling interest in GRMA equals that preferred return. GRNY’s operating agreement provides the holder of the GRNY Preferred Units (Note 23) with allocation, distribution and liquidation rights that differ from the members’ percentage interests. The Company therefore attributes GRNY’s net income or loss using the hypothetical liquidation at book value (“HLBV”) method. Under HLBV, the amount attributed to the non-controlling interest for each period is the change in the amount the holder of the GRNY Preferred Units would receive if GRNY were liquidated at the carrying amounts of its net assets at the balance sheet date, in accordance with the liquidation provisions of the operating agreement, after adjusting for contributions and distributions during the period.
Income taxes
The Company uses the asset and liability method to account for income taxes. Deferred income tax assets and liabilities are determined based on enacted tax rates and laws for the years in which the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
As the Company operates in the cannabis industry, it is subject to the limits of IRC Section 280E, under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production.
11
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 3. | SIGNIFICANT ACCOUNTING POLICIES (continued) |
The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of loss and comprehensive loss.
For interim reporting purposes, the Company computes its income tax provision using an estimated annual effective tax rate method, as required under ASC 740, Income Taxes. Under this method, the Company estimates its annual effective income tax rate and applies that rate to year-to-date ordinary income or loss to determine the interim tax provision. The estimated annual effective tax rate reflects expected annual taxable income or loss, permanent items and discrete items identifiable to specific periods, which are recognized in the period in which they occur. The estimated annual effective tax rate is reviewed and updated at each interim reporting date, with any adjustment recognized in the period of change.
Recently adopted accounting pronouncements
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires enhanced disclosures regarding the nature and composition of certain expense captions presented on the income statement. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. Because the standard only affects disclosures, the Company does not expect adoption to have a material impact on its consolidated financial position, results of operations, or cash flows; however, it expects additional footnote disclosures will be required upon adoption. The Company is currently evaluating the disclosure requirements of the standard.
In July 2025, the Financial Accounting Standards Board issued Accounting Standards Update 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets. The objective of this update is to reduce the cost and complexity of applying the current expected credit loss model to short-term accounts receivable and contract assets. ASU 2025-05 addresses these challenges by introducing a practical expedient that allows entities to assume that current conditions as of the balance sheet date do not change over the remaining life of the asset. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, including interim periods within those fiscal years. The Company adopted ASU 2025-05 as of January 1, 2026 and elected the practical expedient.
| 4. | ACQUISITION OF ROGUE EBC |
On September 16, 2025, the Company entered into a Membership Interest Purchase Agreement to acquire the remaining
12
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 4. | ACQUISITION OF ROGUE EBC (continued) |
Total consideration equals $
| $ | ||||
| Consideration: | ||||
| Cash | ||||
| Business acquisition consideration payable | ||||
| Investment balance | ||||
| Total Consideration | ||||
| Net Assets Acquired: | ||||
| Cash | ||||
| Accounts payable | ( |
) | ||
| Lease liability | ( |
) | ||
| Total net liabilities assumed | ( |
) | ||
| Loss on acquisition of Rogue EBC | ||||
A standalone fair value assessment indicated that the grow license, property and equipment and right-of-use asset had no fair value at the acquisition date due to lack of local operational viability. Because no acquired asset could absorb the excess consideration without immediate impairment, the excess of $
| 5. | ACCOUNTS RECEIVABLE |
The Company’s accounts receivable composition is as follows:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Trade receivables, net of provision for expected credit losses | ||||||||
| Taxes receivable | ||||||||
| Total accounts receivable, net | ||||||||
The changes in the allowance for expected credit losses on trade receivables for the nine months ended September 30, 2026 and year ended December 31, 2025 are as follows:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Provision for expected credit losses | ||||||||
| Write-offs | ( |
) | ( |
) | ||||
| Balance, end of period | ||||||||
Taxes receivable relate to goods and services taxes receivable from the Government of Canada.
13
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 6. | INVENTORY |
The Company’s inventory composition is as follows:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Raw materials | ||||||||
| Work in process | ||||||||
| Finished goods | ||||||||
| Total Inventory | ||||||||
| 7. | WARRANTS ASSET |
The Vireo Warrants are remeasured at fair value through profit and loss at each reporting period using the Black-Scholes option pricing model. The fair value of the Vireo Warrants at September 30, 2026, was estimated to be $
| Date | Expected dividends | Expected volatility |
Risk-free rate of interest |
Expected term (years) |
Closing price per common share |
|||||||||||||||
| December 31, 2025 | % | % | % | $ | (CAD$ | ) | ||||||||||||||
| September 30, 2026 | % | % | % | $ | (CAD$ | ) | ||||||||||||||
On June 5, 2026, Vireo Growth Inc. enacted a 30-1 reverse split. The number of warrants and comparative closing price per common share have been retroactively applied.
During the three and nine months ended September 30, 2026, the Company recorded an unrealized loss on the change in fair value of the warrants asset of $
| 8. | OTHER INVESTMENTS |
The Company accounted for its interest in Rogue EBC, LLC using the equity method until July 14, 2026, when it acquired the remaining membership interest and began consolidating Rogue EBC (Note 4). The carrying amount of the investment at that date, $
14
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 9. | NOTES RECEIVABLE |
Transactions related to the Company’s notes receivable for the nine months ended September 30, 2026 and year ended December 31, 2025, include the following:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Advances | ||||||||
| Accrued interest | ||||||||
| Balance, end of period | ||||||||
Interest income for the three and nine months ended September 30, 2026 was $
| 10. | PROPERTY AND EQUIPMENT |
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Computer and office equipment | ||||||||
| Production equipment and other | ||||||||
| Land | ||||||||
| Construction in progress | ||||||||
| Leasehold improvements | ||||||||
| Gross property and equipment | ||||||||
| Less: Accumulated depreciation | ( |
) | ( |
) | ||||
| Property and equipment, net | ||||||||
| 11. | LEASES |
The Company’s leases consist of land and buildings and equipment used in the cultivation, processing, and warehousing of its products. The leases were classified as either operating leases or finance leases in accordance with ASC 842, Leases.
On April 8, 2026, the Company executed an amendment to extend one of its commercial facility leases and recognized additions to right-of-use assets and operating lease liabilities of $
On August 20, 2026, GRNY, a consolidated subsidiary, commenced an absolute net operating lease of a cannabis cultivation and processing facility in Montgomery, New York.
15
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 11. | LEASES (continued) |
In May and September 2026, the landlord of the
In September 2026, the
A summary of the maturity of contractual undiscounted liabilities associated with the Company’s operating leases and finance leases as of September 30, 2026 is as follows:
| Operating leases | Finance leases | |||||||
| $ | $ | |||||||
| 2026 | ||||||||
| 2027 | ||||||||
| 2028 | ||||||||
| 2029 | ||||||||
| 2030 | ||||||||
| Thereafter | ||||||||
| Total lease payments | ||||||||
| Less: Unamortized interest | ( |
) | ( |
) | ||||
| Total lease liability | ||||||||
| Current portion | ||||||||
| Non-current portion | ||||||||
A summary of the Company’s weighted average discount rate used in calculating lease liabilities and weighted average remaining lease term is as follows:
| September 30, 2026 |
December 31, 2025 |
|||||||
| Operating leases: | ||||||||
| Weighted average discount rate | % | % | ||||||
| Weighted average remaining lease term (years) | ||||||||
| Finance leases: | ||||||||
| Weighted average discount rate | % | % | ||||||
| Weighted average remaining lease term (years) | ||||||||
16
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 12. | LONG-TERM DEBT |
Transactions related to the Company’s long-term debt for the nine months ended September 30, 2026 and year ended December 31, 2025 include the following:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Advances | ||||||||
| Debt issuance costs | ( |
) | ||||||
| Interest and accretion expense | ||||||||
| Transfer to operating lease liability | ( |
) | ||||||
| Payments | ( |
) | ( |
) | ||||
| Balance, end of period | ||||||||
| Current portion | ||||||||
| Non-current portion | ||||||||
A summary of the maturity of contractual undiscounted liabilities associated with the Company’s long-term debt as of September 30, 2026 is as follows:
| Amount ($) |
||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| 2029 | ||||
| 2030 | ||||
| Thereafter | ||||
| Total payments | ||||
| Less: Unamortized interest | ( |
) | ||
| Total long-term debt | ||||
During the three and nine months ended September 30, 2026, the Company recognized interest expense of $
| 13. | DERIVATIVE ASSETS AND LIABILITIES |
| 13.1 | Western Alliance Credit Interest Rate Swap |
The Company measures the interest rate swaps at fair value on a recurring basis. The fair value measurements are categorized within Level 2 of the fair value hierarchy. The Company estimates the fair value of the interest rate swaps using a discounted cash flow model and significant inputs including observable Secured Overnight Financing Rate (“SOFR”) forward curve, discount rates, credit valuation adjustments, counterparty credit risk, and non-performance risk. There were no transfers between fair value hierarchy levels during the nine months ended September 30, 2026.
17
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 13. | DERIVATIVE ASSETS AND LIABILITIES (continued) |
On March 27, 2025, the Company entered into a $
In May and September 2025, the Company entered into interest rate swaps with WAB that effectively fix the interest rate on Tranche 1 and Tranche 2 at 8.07% and 7.53% per annum, respectively. The swaps are measured at fair value using Level 2 inputs and were a net derivative asset of $143,013 at September 30, 2026 (Tranche 1 – $55,041; Tranche 2 – $87,972) (December 31, 2025 – net derivative liability of $137,041).
On May 14, 2025, the Company executed an interest rate swap transaction with WAB for Tranche 1. The Company will bear interest of 8.07% per annum whereas WAB bears 4.32520% plus 400 bps interest per annum. The interest rate swap gives rise to a derivative liability, which was initially recorded at $
On September 15, 2025, the Company executed an interest rate swap transaction with WAB for Tranche 2. The Company will bear interest of 7.53% per annum whereas WAB bears 4.1739% plus 400 bps interest per annum. The interest rate swap gives rise to a derivative liability, which was initially recorded at $
The interest rate swaps were remeasured at September 30, 2026 and were estimated to be a net derivative asset of $
The following is a summary of movements in the interest rate swap during the nine months ended September 30, 2026 and year ended December 31, 2025:
| Interest rate swaps | $ | |||
| Balance, December 31, 2024 | ||||
| Initial recognition | ( |
) | ||
| Unrealized loss | ( |
) | ||
| Balance, December 31, 2025 | ( |
) | ||
| Unrealized gain | ||||
| Balance, September 30, 2026 | ||||
| 13.2 | Warrant liabilities |
On January 1, 2026, as a result of the change in functional currency from CAD to USD (Note 2.1), certain warrants exercisable in CAD no longer met the criteria for equity classification. Following the change in functional currency, the warrants no longer represented an instrument exchangeable into a fixed number of its shares for a fixed amount of proceeds. As such, the warrants are accounted for as derivative liabilities measured at fair value. The previously recorded equity balances associated with these warrants were derecognized at their fair values measured on January 1, 2026 with the resulting difference recorded within paid in capital. No gain or loss was recognized in earnings upon reclassification.
18
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 13. | DERIVATIVE ASSETS AND LIABILITIES (continued) |
The warrant liabilities are subsequently measured at fair value at each reporting date, with changes in fair value recognized through profit or loss. The fair value of the warrant liabilities is determined at each reporting date using the Black-Scholes option pricing model, which incorporates significant unobservable inputs, including expected stock price volatility and estimated term, and the warrant liabilities are classified within Level 3 of the fair value hierarchy.
The following is a summary of movements in the warrant liabilities during the nine months ended September 30, 2026 and year ended December 31, 2025:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Fair value of warrants on reclassification | ||||||||
| Unrealized gain on warrant liability | ( |
) | ||||||
| Balance, end of period | ||||||||
During the three and nine months ended September 30, 2026, the Company recorded an unrealized loss of $
The warrant liabilities were measured using the following inputs to the Black-Scholes option pricing model:
| Date | Expected dividends | Expected volatility | Risk-free rate of interest |
Expected term (years) |
Exercise price | Closing price per common share |
||||||||||||||||||
| January 1, 2026 | % | % | % | $ | ) | $ | 0.51 (CAD$ | ) | ||||||||||||||||
| September 30, 2026 | % | % | % | $ | ) | $ | (CAD$ | ) | ||||||||||||||||
As at September 30, 2026 and December 31, 2025, the following warrants were issued and outstanding:
| Expiry date | Number of warrants outstanding |
Weighted average exercise price |
||||||
| $ | ) | |||||||
| 14. | SHARE CAPITAL |
| 14.1 | Capital stock |
The Company is authorized to issue an unlimited number of Subordinate Voting Shares (“SV Shares”) and Multiple Voting shares (“MV Shares”) at no par value, and an unlimited number of preferred shares issuable in series.
19
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 14. | SHARE CAPITAL (continued) |
| 14.2 | Dividends |
Our Board of Directors may declare dividends on one or more class of shares to the exclusion of the others, or declare dividends at different rates on different classes of shares, at their discretion. No dividends shall be declared on SV Shares or the MV Shares if to do so would reduce the value of the net assets of the Company to less than the paid in capital of the common stock.
During the three and nine months ended September 30, 2026, the Company’s subsidiary, Golden Harvests, declared and paid dividends of $
During the three and nine months ended September 30, 2026, the Company’s subsidiary, GRMA, declared and paid preferred return distributions on the voting preferred units of GRMA (the “GRMA Units”) of $
| 15. | WARRANTS CLASSIFIED AS EQUITY |
The following table summarizes the warrant activities for the nine months ended September 30, 2026 and the year ended December 31, 2025:
| Number of warrants outstanding |
Weighted average exercise price |
Weighted average remaining life (years) |
Aggregate intrinsic value ($) |
|||||||||||||
| Balance, December 31, 2024 | $ | ) | ||||||||||||||
| Exercise to SV shares for December warrants | ) | $ | (CAD$ | ) | ||||||||||||
| Exercise to SV shares for July warrants | ) | $ | (CAD$ | ) | ||||||||||||
| Exercise to SV shares for August warrants | ) | $ | (CAD$ | ) | ||||||||||||
| Forfeit and return of cancelled warrants | ( |
) | $ | ) | - | |||||||||||
| Balance, December 31, 2025 | $ | ) | ||||||||||||||
| Reclassified to warrant liabilities (Note 13.2) | ( |
) | $ | ) | - | |||||||||||
| Balance, September 30, 2026 | - | |||||||||||||||
Effective January 1, 2026, in connection with the change in the Company’s functional currency to the United States dollar, the exercise price of the outstanding warrants was no longer denominated in the Company’s functional currency. Accordingly, the warrants no longer qualify for equity classification and were reclassified to warrant liabilities at their fair value of $
20
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 16. | STOCK OPTIONS AND RESTRICTED STOCK UNITS |
The Company’s board of directors adopted the 2020 Equity Incentive Plan (the “Plan”) on July 21, 2020. The maximum number of common shares that may be issued in respect of awards under the Plan is equal to 20% of the total SV Shares outstanding. The Company may issue stock options, stock appreciation rights, restricted stock and restricted stock units (each, an “RSU”).
| 16.1 | Stock options |
The following table summarizes the stock option movements for the nine months ended September 30, 2026 and year ended December 31, 2025:
| Number of stock options |
Weighted average exercise price |
Aggregate intrinsic value ($USD) |
||||||||||
| Balance, December 31, 2024 | $ | (CAD$ | ) | |||||||||
| Granted | $ | (CAD$ | ) | - | ||||||||
| Exercised | ) | $ | (CAD$ | ) | ||||||||
| Forfeited | ) | $ | (CAD$ | ) | - | |||||||
| Balance, December 31, 2025 | $ | (CAD$ | ) | |||||||||
| Granted | $ | (CAD$ | ) | - | ||||||||
| Exercised | ) | $ | (CAD$ | ) | ||||||||
| Forfeited / Cancelled | ) | $ | (CAD$ | ) | - | |||||||
| Balance, September 30, 2026 | $ | (CAD$ | ) | |||||||||
As at September 30, 2026, stock options outstanding had a weighted average remaining contractual life of years, and stock options were exercisable with an aggregate intrinsic value of $.
During the three and nine months ended September 30, 2026, the Company recognized share-based compensation expense of $ and $, respectively (three and nine months ended September 30, 2025 - $ and $ respectively) related to vesting of stock options.
As at September 30, 2026, the Company has unrecognized stock-based compensation expense of $ associated with outstanding stock options.
The Company computes the fair value of stock options granted using the Black-Scholes option pricing model. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees and directors is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee share purchase option grants. The Company utilizes expected volatility based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate is based on the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.
21
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 16. | STOCK OPTIONS AND RESTRICTED STOCK UNITS (CONTINUED) |
| 16.2 | Restricted stock units |
The following table summarizes the RSU’s movements for the nine months ended September 30, 2026 and year ended December 31, 2025:
| Number of RSU’s (#) |
Weighted average grant date fair value ($) |
Aggregate intrinsic value ($) |
||||||||||
| Balance, December 31, 2024 | $ | (CAD$ | ) | |||||||||
| Granted to employees | $ | (CAD$ | ) | |||||||||
| Vested | ) | $ | (CAD$ | ) | ||||||||
| Balance, December 31, 2025 | $ | (CAD$ | ) | |||||||||
| Granted | $ | (CAD$ | ) | |||||||||
| Cancelled | ) | - | - | |||||||||
| Balance, September 30, 2026 | $ | (CAD$ | ) | |||||||||
As at September 30, 2026, the weighted average remaining vesting period of outstanding RSU’s was years.
The Company computes the fair value of RSUs granted based on the Company’s closing share price at the grant date. During the three and nine months ended September 30, 2026, share-based compensation expense included $ related to RSUs for each period (three and nine months ended September 30, 2025 – $nil and $, respectively).
As of September 30, 2026, there was $ in unamortized RSU vesting expense.
| 17. | EARNINGS PER SHARE |
The calculation of earnings per share for the three and nine months ended September 30, 2026 and 2025 is as follows:
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| $ | $ | $ | $ | |||||||||||||
| Net income (loss) attributable to shareholders | ( |
) | ( |
) | ||||||||||||
| Weighted average number of SV Shares outstanding | ||||||||||||||||
| Dilutive effect of stock options outstanding | ||||||||||||||||
| Dilutive effect of RSU’s outstanding | ||||||||||||||||
| Dilutive effect of warrants outstanding | ||||||||||||||||
| Diluted weighted average number of SV Shares outstanding | ||||||||||||||||
| Basic net income (loss) per share | ( |
) | ( |
) | ||||||||||||
| Diluted net income (loss) per share | ( |
) | ( |
) | ||||||||||||
22
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 17. | EARNINGS PER SHARE (CONTINUED) |
The following table displays the securities that have been excluded from the computation because their effects would be anti-dilutive:
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| # | # | # | # | |||||||||||||
| Stock options | ||||||||||||||||
| RSU’s | ||||||||||||||||
| GRNY Preferred Units (Note 23) | ||||||||||||||||
| Warrants (Note 13.2) | ||||||||||||||||
| Total | ||||||||||||||||
| 18. | INCOME TAXES |
The Company is a Canadian resident company, as defined in the Income Tax Act (Canada) (the “ITA”), for Canadian income tax purposes. However, it has subsidiaries that are treated as United States corporations for US federal income tax purposes per the Internal Revenue Code (US) (“IRC”) and are thereby subject to federal income tax on their worldwide income. As a result, the Company is subject to taxation both in Canada and the United States.
The Company computes its interim provision for income taxes by applying an estimated annual effective tax rate to year-to-date ordinary income or loss, adjusted for the tax effect of discrete items recognized in the interim period in which they occur. Significant judgment is required in evaluating the Company’s uncertain tax position and determining the provision for income taxes.
A summary of the Company’s income tax expense and effective tax rate is as follows:
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| $ | $ | $ | $ | |||||||||||||
| Income (loss) before income taxes and noncontrolling interest | ( |
) | ( |
) | ||||||||||||
| Income tax expense | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Effective tax rate | ( |
%) | % | ( |
%) | % | ||||||||||
The effective tax rate for the three and nine months ended September 30, 2026 differs from the customary relationship between income tax and pre-tax income primarily because of expenses that are non-deductible under IRC Section 280E, the increase in the Company’s uncertain tax position liability, inclusive of interest and penalties, and the loss on acquisition of Rogue EBC (Note 4), for which no tax benefit was recognized.
As at September 30, 2026, the Company had gross deferred tax assets of $
23
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 18. | INCOME TAXES (CONTINUED) |
As at September 30, 2026, the Company recorded an uncertain tax liability of $12,094,117 (December 31, 2025 - $8,383,888) for uncertain tax positions primarily related to the treatment of certain transactions and deductions under IRC Section 280E based on legal interpretations that challenge the Company’s tax liability under IRC Section 280E. These uncertain tax positions, inclusive of penalties and interest, are included in Other non-current liabilities on the condensed consolidated balance sheets, net of net operating loss carry-forwards.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. Other than increases from positions taken in the current period and accrued interest and penalties, there are no positions for which it is reasonably possible that the uncertain tax benefit will significantly increase or decrease within twelve months. The Company files income tax returns in the United States, including various state jurisdictions, and in Canada, which remain open to examination by the respective jurisdictions for the 2018 tax year to the present.
| 19. | SUPPLEMENTAL CASH FLOW INFORMATION |
The changes to the Company’s operating assets and liabilities for the nine months ended September 30, 2026 and 2025 are as follows:
| Nine months ended September 30, |
||||||||
| 2026 | 2025 | |||||||
| $ | $ | |||||||
| Accounts receivable | ( |
) | ( |
) | ||||
| Inventory | ( |
) | ( |
) | ||||
| Prepaid expenses | ( |
) | ( |
) | ||||
| Accounts payable and accrued liabilities | ( |
) | ||||||
| Income tax payable | ( |
) | ||||||
| Uncertain tax position liability | ||||||||
| Total | ( |
) | ||||||
Interest and income taxes paid in cash for the nine months ended September 30, 2026 and 2025 were as follows:
| Nine months ended September 30, |
||||||||
| 2026 | 2025 | |||||||
| $ | $ | |||||||
| Income taxes paid in cash | ||||||||
| Interest paid in cash | ||||||||
24
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 19. | SUPPLEMENTAL CASH FLOW INFORMATION (CONTINUED) |
Non-cash investing and financing activities for the nine months ended September 30, 2026 and 2025 are as follows:
| Nine months ended September 30, |
||||||||
| 2026 | 2025 | |||||||
| $ | $ | |||||||
| Fair value of SV Shares issued to settle convertible debentures | ||||||||
| Reclassification of warrants from equity to warrant liability (Note 13.2) | ||||||||
| Fair value SV Shares to be issued for debt facility commitment fee | ||||||||
| Transfer of long-term debt to operating lease liability | ||||||||
| Property and equipment acquired through finance lease liabilities | ||||||||
| Right-of-use assets resulting from operating lease liabilities | ||||||||
| Right-of-use assets resulting from finance lease liabilities | ||||||||
| Right-of-use assets resulting from transfer from property and equipment | ||||||||
| 20. | RELATED PARTY TRANSACTIONS |
During the three and nine months ended September 30, 2026 and 2025, the Company incurred the following related party transactions.
Transactions with related parties
Related parties of the Company include affiliates, entities for which investments are accounted for by the equity method, officers, and directors of the Company and members of their immediate families, and management involved in the financial statement preparation and members of their immediate families.
Transactions with related parties are presented in the following table:
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| $ | $ | $ | $ | |||||||||||||
| Salaries and consulting fees | ||||||||||||||||
| Lease payments made to CEO | ||||||||||||||||
| Fees paid to entity controlled by spouse of majority owner | ||||||||||||||||
| Share-based compensation expense | ||||||||||||||||
| Total | ||||||||||||||||
Salaries and consulting fees are included in general and administrative expenses, and lease payments made to the CEO are included in cost of goods sold. Fees paid to the entity controlled by the spouse of the majority owner of ABCO Holdings (Blackwell, Note 24) were capitalized to property and equipment as construction in progress for the ABCO Grandview Phase II and Phase III projects in Paulsboro, New Jersey.
As of September 30, 2026, the Company had amounts due to related parties of $
25
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 20. | RELATED PARTY TRANSACTIONS (CONTINUED) |
Amounts due to related parties under acquisition and debt agreements
The following table sets out portions of debt pertaining to related parties which are included in consideration payable on business acquisitions and long-term debt:
| CEO(1) | Director(1) | GM(1) | ABCO Holdings, Inc.(2) | Total | ||||||||||||||||
| $ | $ | $ | $ | $ | ||||||||||||||||
| Balance, December 31, 2024 | ||||||||||||||||||||
| Interest | ||||||||||||||||||||
| Payments | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Balance, December 31, 2025 | ||||||||||||||||||||
| Interest | ||||||||||||||||||||
| Payments | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Balance, September 30, 2026 | ||||||||||||||||||||
| (1) | |
| (2) |
As part of the agreements transacted during the year ended October 31, 2020, to acquire interest in GR Michigan and Canopy, the Company incurred business acquisition consideration payable of $
Pursuant to the Canopy purchase agreement executed on April 24, 2024, the Company, through GR Unlimited, acquired the remaining 13% of the membership units in Canopy. As part of this transaction, the Company purchased a
During April 2024, the Company, through Canopy, acquired an additional
On May 29, 2025, Canopy Management LLC was dissolved, and all existing agreements and obligations were assigned and transferred to Grown Rogue Unlimited, LLC.
26
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 21. | FINANCIAL INSTRUMENTS |
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis, categorized within the fair value hierarchy:
|
Level in Hierarchy |
September 30, 2026 |
December 31, 2025 |
||||||||
| $ | $ | |||||||||
| Financial Assets: | ||||||||||
| Warrants asset | Level 2 | |||||||||
| Derivative asset | Level 2 | |||||||||
| Financial Liabilities: | ||||||||||
| Derivative liability | Level 2 | |||||||||
| Warrant liabilities | Level 3 | |||||||||
The fair value of the warrants asset is measured using the Black-Scholes option pricing model with inputs including the underlying share price, risk-free interest rate, expected volatility, and remaining term, consistent with the valuation methodology applied in the Company’s audited consolidated financial statements for the year ended December 31, 2025. The warrant liabilities are also measured using the Black-Scholes option pricing model, using the inputs disclosed in Note 13.2. The derivative asset and derivative liability, which relate to the Western Alliance interest rate swaps, are measured using a discounted cash flow model that takes into account observable inputs such as interest rate curves, forward curves and counterparty credit risk (Note 13.1).
| 22. | SEGMENT REPORTING |
The reportable segments are those operations whose operating results are reviewed by the chief operating decision maker (“CODM”) to make decisions about resources to be allocated. The Company’s CODM is the CEO and is responsible for the management of the Company. Operating results are reviewed with respect to resource allocation and for which discrete financial information is available. Inter-segment transactions are recorded at amounts that reflect normal third-party terms and conditions, with inter-segment profits eliminated from the cost base of the segment incurring the charge. The Company has identified three operating segments:
| ● | Oregon segment represents cannabis production and sales activities in Oregon; |
| ● | Michigan segment represents cannabis production and sales activities in Michigan; and |
| ● | New Jersey segment represents cannabis production and sales activities in New Jersey. |
The Company’s general corporate administration expenses and the results of its Illinois, Minnesota and New York operations, which are being provisioned, are included within “Corporate” to reconcile the reportable segments to the financial statements. The Company’s CODM reviews the results of the Company’s operating segments based on the total revenues, gross profit and net income (loss) in his evaluation of the performance of the operating segments to make decisions regarding resource allocations within the Company.
27
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 22. | SEGMENT REPORTING (CONTINUED) |
Segmented operational activity for the three months ended September 30, 2026 and 2025 is as follows:
| Segments | Oregon | Michigan | New Jersey | Corporate | Total | |||||||||||||||
| $ | $ | $ | $ | $ | ||||||||||||||||
| September 30, 2026: | ||||||||||||||||||||
| Total revenue | ||||||||||||||||||||
| Gross profit | ||||||||||||||||||||
| Net income (loss) | ( |
) | ( |
) | ||||||||||||||||
| September 30, 2025: | ||||||||||||||||||||
| Total revenue | ||||||||||||||||||||
| Gross profit | ||||||||||||||||||||
| Net income (loss) | ( |
) | ( |
) | ||||||||||||||||
Segmented operational activity for the nine months ended September 30, 2026 and 2025 is as follows:
| Segments | Oregon | Michigan | New Jersey | Corporate | Total | |||||||||||||||
| $ | $ | $ | $ | $ | ||||||||||||||||
| September 30, 2026: | ||||||||||||||||||||
| Total revenue | ||||||||||||||||||||
| Gross profit | ||||||||||||||||||||
| Net income (loss) | ( |
) | ( |
) | ||||||||||||||||
| September 30, 2025: | ||||||||||||||||||||
| Total revenue | ||||||||||||||||||||
| Gross profit | ||||||||||||||||||||
| Net income (loss) | ( |
) | ||||||||||||||||||
All revenue for the three and nine months ended September 30, 2026 and 2025 was earned in the United States. For the three and nine months ended September 30, 2026 and 2025, no customer represented more than 10% of the Company’s net revenue. As at September 30, 2026 and December 31, 2025, no customer represented more than 10% of the Company’s receivables.
A summary of the Company’s long-lived tangible assets disaggregated by geographic area is as follows:
| Segments | Oregon | Michigan | New Jersey | Corporate | Total | |||||||||||||||
| $ | $ | $ | $ | $ | ||||||||||||||||
| Non-current assets other than financial instruments: | ||||||||||||||||||||
| As at September 30, 2026 | ||||||||||||||||||||
| As at December 31, 2025 | ||||||||||||||||||||
28
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 23. | NON-CONTROLLING INTERESTS |
The activity in non-controlling interests within shareholders’ equity for the three and nine months ended September 30, 2026 and year ended December 31, 2025 are as follows:
| September 30, 2026 |
December 31, 2025 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Sale of 20% ownership of GRMA | ||||||||
| Dividends issued from Golden Harvest to minority owner | ( |
) | ( |
) | ||||
| Dividends issued from GRMA to minority owner | ( |
) | ||||||
| Net income for the period attributed to non-controlling interest | ||||||||
| Balance, end of period | ||||||||
During the nine months ended September 30, 2026, the Company sold 20% of its ownership in GRMA through the sale of 20 GRMA Units at a par value of $ per unit for gross proceeds of $
Redeemable non-controlling interest
On August 20, 2026,
Because a deemed liquidation event is not solely within the Company’s control, the GRNY Preferred Units are classified as redeemable non-controlling interest outside of permanent equity. There are no fixed or determinable redemption requirements. As a deemed liquidation event was not probable as of September 30, 2026, the carrying amount has not been adjusted to the redemption amount. The net income or loss of GRNY is attributed to the GRNY Preferred Units using the hypothetical liquidation at book value (“HLBV”) method. Because the holder of the GRNY Preferred Units contributed all of GRNY’s capital, the net loss of GRNY of $1,089,393 for the three and nine months ended September 30, 2026 was attributed entirely to the redeemable non-controlling interest. The issuance of the GRNY Preferred Units had no effect on equity attributable to shareholders of the Company.
29
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 23. | NON-CONTROLLING INTERESTS (CONTINUED) |
The changes in redeemable non-controlling interest during the three and nine months ended September 30, 2026 were as follows:
| Three months ended September 30, 2026 |
Nine months ended September 30, 2026 |
|||||||
| $ | $ | |||||||
| Balance, beginning of period | ||||||||
| Issuance of GRNY Preferred Units | ||||||||
| Net loss attributed to redeemable non-controlling interest | ( |
) | ( |
) | ||||
| Balance, September 30, 2026 | ||||||||
| 24. | COMMITMENTS AND CONTINGENCIES |
On September 22, 2022, the Securities and Exchange Commission (“SEC”) instituted administrative proceedings against the Company under Section 12(j) of the Securities Exchange Act of 1934 (the “Exchange Act”), alleging violations of the Exchange Act for failing to timely file its periodic reports. On June 22, 2026, the matter was dismissed.
In December 2025, ABCO entered into a cost-plus-fee agreement, without a guaranteed maximum price, with Blackwell & Associates (“Blackwell”), a related party (Note 20), for the Grandview Phase II project in Paulsboro, New Jersey, at an estimated cost of $1,430,000, including Blackwell’s fee. In September 2026, the agreement was amended to add the Grandview Phase III work, with a control budget of $1,327,850 before Blackwell’s fee (approximately $1,527,000 including the fee), on the same terms. ABCO may terminate the agreement for convenience without paying a termination fee.
Sea Craft, LLC Acquisition
On March 11, 2026, the Company, through its majority-owned subsidiary GRMA, entered into a Membership Interest Purchase Agreement with the members of Sea Craft, LLC (“Sea Craft”), the holder of an Illinois Adult Use Cannabis Craft Grower License. Pursuant to the agreement, and subject to receipt of the regulatory approvals necessary to consummate the transaction, GRMA agreed to acquire 49% of Sea Craft’s issued and outstanding ownership interests. The agreement also grants the majority holder of Sea Craft’s remaining issued and outstanding ownership interests an option, subject to certain conditions precedent, to require GRMA to purchase those remaining interests.
As at September 30, 2026, the regulatory approvals required to consummate the transaction had not been obtained, and accordingly, the acquisition had not closed.
GRNY loan commitment
On August 20, 2026,
30
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 25. | VARIABLE INTEREST ENTITY |
PharmaCann of New York, LLC (“PCNY”) is a New York licensed medical and adult-use cannabis operator. It runs a cultivation and processing facility in Hamptonburgh, New York and four dispensaries, and is wholly owned by PharmaCann Inc.
On August 20, 2026, GRNY, a 51%-owned consolidated subsidiary of the Company (Note 23), entered into three agreements with PCNY (together, the “PCNY Arrangement”). Under the goods and services agreement, GRNY provides operational and administrative support services to PCNY’s facilities. In return, GRNY is entitled to a management fee equal to the facilities’ revenues less their operating expenses. Under the secured line of credit, GRNY may advance up to $
The PCNY Arrangement is intended to support PCNY’s operations while GRNY and PharmaCann Inc. negotiate GRNY’s acquisition of PCNY. Any such acquisition is subject to regulatory approval. At September 30, 2026, no purchase agreements had been executed.
PCNY is a variable interest entity because its equity at risk is not sufficient to finance its activities without additional subordinated financial support. GRNY holds variable interests in PCNY through the management fee, the line of credit and the sublease.
The Company concluded that GRNY is not PCNY’s primary beneficiary. PCNY’s economic performance is driven most significantly by its cultivation, processing and dispensing operations, labor and hiring, capital and operating spending, its budget and business strategy, and its licences and regulatory matters. GRNY must obtain PCNY’s written authorization before taking any definitive action to operate the facilities. PCNY retains control of hiring, its licences and its regulatory relationships. Decisions on the budget, business strategy, material contracts and significant capital expenditure require the consent of both GRNY and PCNY, which are unrelated parties. GRNY therefore does not alone have the power to direct these activities, and does not consolidate PCNY.
The Company considered that GRNY’s economic exposure is disproportionate to its decision-making rights. That imbalance reflects New York regulations that reserve control of licensed operations to the licensee pending regulatory approval of a change in ownership.
At September 30, 2026, the carrying amount of GRNY’s variable interests in PCNY was $
Maximum exposure to loss equals the amounts advanced to PCNY.
GRNY is also the lessee of the Hamptonburgh facility and remains liable under that lease whether or not the sublease continues (see Note 11).
31
Grown Rogue International Inc.
Notes to the Condensed Consolidated Financial Statements
Unaudited
| 26. | SUBSEQUENT EVENTS |
The Company evaluated subsequent events through the date the financial statements were issued, and determined that the following subsequent events occurred as of that date:
On October 26, 2026, the Company’s shareholders approved a consolidation of the Company’s subordinate voting and multiple voting shares on the basis of one post-consolidation share for up to thirty pre-consolidation shares, as determined by the shareholder vote. The consolidation had not been effected as of the date these financial statements were issued.
On November 4, 2026, GRNY advanced an additional $
32
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
You should read the following discussion and analysis of the Company’s financial condition and results of operations together with the Company’s financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and related footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2025.
Special Note Regarding Forward-Looking Statements
Certain of the information included in this Quarterly Report on Form 10-Q (this “Quarterly Report”) is based upon express or implied estimates, projections or other “forward-looking statements” within the meaning of the U.S. federal securities laws. Such forward-looking statements include any projections or estimates made by Grown Rogue International, Inc. (“we,” “us,” “our,” or the “Company”) and our management in connection with our business operations. These statements may relate to future events or our future financial performance. This Quarterly Report may also contain estimates, projections data, and other information concerning our industry, our business and the markets for our products, including data regarding the estimated size of those markets and their projected growth rates, derived from reports, research surveys, studies and similar materials prepared by third parties, industry and general publications, government data and similar sources.
In some cases you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of those terms or other comparable terminology that does not relate strictly to historical or factual matters. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results may vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested therein. Such forward-looking statements involve various risks and uncertainties and other factors, including those risks described in Item 1A – “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”) and in Part II, Item 1A – “Risk Factors” of this Quarterly Report, as may be updated from time to time in our periodic filings with the SEC which are accessible on the SEC’s website at www.sec.gov, and which may cause our actual results, levels of activities, performance or achievements to be materially different from any projected results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should evaluate all forward-looking statements made in this Quarterly Report in the context of these risks and uncertainties. All forward-looking statements in this Quarterly Report apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this Quarterly Report and in other filings we make with the SEC. Except as required by applicable law, including federal securities laws, we do not undertake to update or revise any of forward-looking statements to reflect subsequent events or conform those statements to actual results.
Business Overview
The Company is a vertically integrated, multi-state cannabis operator focused on high-quality, low-cost production of premium flower and pre-roll products. Through its subsidiaries, the Company cultivates, manufactures, possesses, and distributes cannabis in the United States, with operations in Oregon, Michigan and New Jersey, and with operations being provisioned in Illinois, New York and Minnesota. Flower-based products, including indoor flower, sungrown (outdoor) flower, and pre-rolls, remain the Company’s strategic focus, as flower continues to lead category share in most state markets.
The Company manages indoor and outdoor cultivation in the Rogue Valley of Southern Oregon, an indoor cultivation facility in Bay City, Michigan operated through Golden Harvests, LLC, and indoor cultivation in Paulsboro, New Jersey operated through ABCO Garden State, LLC. In New York, the Company’s 51%-owned subsidiary Grown Rogue New York, LLC entered into a lease of the Hamptonburgh facility (14 Hudson Crossing Drive, Montgomery, New York), a cannabis cultivation and processing facility, and a series of agreements with PharmaCann of New York, LLC during the third quarter of 2026. In Minnesota, the Company is building out a production facility in Fridley, Minnesota through Gopher Gardens, LLC. Each of these developments is discussed under “Recent Developments” below.
For a more detailed description of our business, history, products, brand strategy, and competitive positioning, refer to “Part I, Item 1. Business” in our Annual Report.
33
Recent Developments
In addition to events discussed elsewhere in this Quarterly Report, the following developments occurred during, or have a direct bearing on, the three and nine months ended September 30, 2026:
Acquisition of the remaining interest in Rogue EBC. On September 16, 2025, the Company entered into a Membership Interest Purchase Agreement to acquire the remaining 30% membership interest in Rogue EBC, LLC (“Rogue EBC”). On July 14, 2026, following receipt of regulatory approval, the Company completed the acquisition and obtained control of Rogue EBC, which has been consolidated from that date. Previously, the Company accounted for its interest in Rogue EBC as a joint venture using the equity method. Total cash consideration for the remaining interest was $1,500,000, comprising a $500,000 cash advance paid prior to closing and deferred cash consideration of $1,000,000, payable as $500,000 on January 14, 2027 and $500,000 on the earlier of first harvest and October 14, 2027. The Company does not expect any harvests at the Rogue EBC facility over the next 15 months. The transaction was accounted for as an asset acquisition under ASC 805. Total consideration was $2,431,831, comprising a $500,000 cash advance, $909,401 representing the combined initial present value of the deferred payments, and the $1,022,430 carrying amount of the Company’s previously held investment in Rogue EBC. Net assets acquired comprised cash, accounts payable and a lease liability, representing a net liability position of $2,598,501. A standalone fair value assessment indicated that the grow license, property and equipment and right-of-use asset had no fair value at the acquisition date due to the lack of local operational viability. Because no acquired asset could absorb the excess consideration without immediate impairment, the excess of $5,030,332 was recognized as a loss on acquisition in the third quarter of 2026. For further discussion, see Note 4 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
New York expansion. On August 20, 2026, Grown Rogue New York, LLC (“GRNY”), a subsidiary of the Company, completed the following transactions:
| ● | GRNY Preferred Units. GRNY issued 49 convertible preferred units (the “GRNY Preferred Units”) to a third-party investor for $10,000,000. The GRNY Preferred Units are entitled to priority distributions of $1,000,000 on August 20, 2027 and $2,000,000 on each anniversary thereafter, with unpaid distributions accruing at 20% per annum. Until August 20, 2031, the holder may convert all of the GRNY Preferred Units into SV Shares of the Company at $0.55 per share, increasing to $0.65 after 36 months and to $0.76 after 48 months. GRNY may redeem all of the GRNY Preferred Units at 150% of the capital contribution (plus additional amounts after the third anniversary), in which case the Company would issue the holder 10,000,000 warrants exercisable at $0.60 per share for seven years. Because a deemed liquidation event is not solely within the Company’s control, the GRNY Preferred Units are presented as redeemable non-controlling interest outside of permanent equity. Following the issuance, the Company holds a 51% interest in GRNY. For further discussion, see Note 23 to the unaudited condensed consolidated financial statements. |
| ● | Hamptonburgh facility lease. GRNY commenced an absolute net operating lease of the Hamptonburgh facility, which it subleases to PCNY, with a 42-month initial term and a required 24-month extension or a $2,400,000 termination fee. The Company is reasonably certain to extend the lease, so the lease term is 66 months, ending February 2032. The Company recognized a right-of-use asset and lease liability of $22,500,000 each at commencement. The lease is guaranteed by the Company and Grown Rogue Unlimited, LLC. |
| ● | Arrangements with PharmaCann of New York, LLC. GRNY entered into three agreements with PharmaCann of New York, LLC (“PCNY”) (together, the “PCNY Arrangement”): a goods and services agreement, under which GRNY provides operational and administrative support services to PCNY’s facilities in exchange for a management fee equal to the facilities’ revenues less their operating expenses; a secured line of credit, under which GRNY may advance up to $9,000,000 to PCNY, at GRNY’s sole discretion, to fund PCNY’s working capital and capital expenditures, secured by PCNY’s assets; and a sublease of the Hamptonburgh facility to PCNY. PCNY is a licensed New York medical and adult-use cannabis operator with a cultivation and processing facility and four dispensaries. The PCNY Arrangement is intended to support PCNY’s operations while GRNY and PharmaCann Inc. negotiate GRNY’s |
34
acquisition of PCNY. PCNY is a variable interest entity. GRNY was not its primary beneficiary at September 30, 2026, and PCNY was not consolidated. At September 30, 2026, GRNY’s maximum exposure to loss was $2,000,000, comprising a loan receivable of $484,420 and a deposit of $1,515,580 paid toward the consideration for the proposed acquisition, which will be applied to the acquisition consideration on closing. On November 4, 2026, GRNY advanced an additional $1,000,000 to PCNY under the secured line of credit, reducing the undrawn amount of the line of credit to $7,500,000. GRNY continues to negotiate definitive agreements for the acquisition of PCNY’s license and assets, which would be subject to regulatory approval; no purchase agreements had been executed as of the date of this Quarterly Report. For further discussion, see Notes 25 and 26 to the unaudited condensed consolidated financial statements.
| ● | GRNY loan commitment. The holder of the GRNY Preferred Units committed to lend GRNY up to $5,000,000 until August 20, 2027, at 15% per annum, repayable August 20, 2030. For each $1 advanced, the lender will receive 0.901 warrants of the Company exercisable at $0.55 per share for five years. In consideration for the commitment, the Company owes 300,000 SV Shares, with a fair value of $138,000, which had not been issued as at September 30, 2026. No amounts had been advanced at September 30, 2026. For further discussion, see Note 24 to the unaudited condensed consolidated financial statements. |
Minnesota build-out. In May and September 2026, the landlord of the Company’s Fridley, Minnesota facility funded a tenant improvement allowance totaling $2,750,000. The Company repays the allowance as additional rent with interest at 14.5%, through monthly payments and a balloon payment due 36 months after each draw. The allowance is accounted for as a lease incentive, and at September 30, 2026, operating lease liabilities included $2,733,333 related to it. The balance related to the initial draw, presented within long-term debt at June 30, 2026, is presented within operating lease liabilities at September 30, 2026. In September 2026, the Company also commenced a ten-year, non-cancellable finance lease of HVAC equipment at the Fridley facility for fixed payments of $40,000 per month. At September 30, 2026, the related right-of-use asset was $2,521,031 and the lease liability was $2,557,594.
Illinois – SEA Craft. As previously disclosed, on March 11, 2026, the Company, through its 80%-owned subsidiary Grown Rogue Management Associates, LLC (“GRMA”), entered into a Membership Interest Purchase Agreement to acquire 49% of SEA Craft, LLC (“SEA Craft”), the holder of an Illinois Adult Use Cannabis Craft Grower License, together with related option arrangements for the remaining interests. The transaction is subject to regulatory approval by the Illinois Department of Agriculture. As at September 30, 2026, the required regulatory approvals had not been obtained, and the acquisition had not closed. To support the Illinois operation, during the first quarter of 2026 the Company sold a 20% non-controlling interest in GRMA, in the form of 20 preferred units (the “GRMA Units”), for net proceeds of $2,985,000. During the three and nine months ended September 30, 2026, GRMA paid preferred return distributions on the GRMA Units of $225,616 and $253,973, respectively.
ABCO Phase II and Phase III construction. As previously disclosed in our Annual Report, on December 8, 2025, ABCO entered into an agreement with Blackwell & Associates (“Blackwell”) for the construction of the Grandview Phase II project located at 1425 Grandview Avenue, Paulsboro, New Jersey, on a cost-plus-a-fee basis without a guaranteed maximum price. The total estimated cost is approximately $1,430,000. In September 2026, the agreement was amended to add the Grandview Phase III work, with a control budget of $1,327,850 before Blackwell’s fee (approximately $1,527,000 including the fee), on the same terms. Construction continued through the date of this report. Blackwell is considered a related party as it is controlled by the spouse of the majority owner of ABCO Holdings, Inc.
Functional currency change and warrant liability. Effective January 1, 2026, the Company changed its functional currency from the Canadian Dollar to the U.S. dollar, applied prospectively in accordance with ASC 830, Foreign Currency Matters. As a result, 4,000,000 warrants with CAD-denominated exercise prices no longer met the criteria for equity classification and were reclassified to a warrant liability of $1,539,665 on January 1, 2026. During the three and nine months ended September 30, 2026, the Company recorded an unrealized loss of $64,444 and an unrealized gain of $369,103, respectively, on changes in the fair value of the warrant liability, resulting in a warrant liability balance of $1,170,562 at September 30, 2026. For further discussion, see Notes 2.1 and 13.2 to the unaudited condensed consolidated financial statements.
35
Equity incentive awards. On July 21, 2026, the Company’s board of directors approved the grant of 400,000 stock options and 2,490,000 restricted share units (“RSUs”) to directors, officers and employees. The stock options have an exercise price of $0.42 (CAD$0.60) and expire on July 21, 2030. The RSUs vest in tranches through January 1, 2029. Certain of the awards provide for immediate vesting upon termination of the holder’s engagement with the Company. On January 12, 2026, the Company issued 200,000 SV Shares on the exercise of stock options for proceeds of $21,839. Total SV Shares issued and outstanding were 249,938,980 at September 30, 2026 (December 31, 2025 – 249,738,980).
Share consolidation. On October 26, 2026, the Company’s shareholders approved a consolidation of the Company’s subordinate voting and multiple voting shares on the basis of one post-consolidation share for up to thirty pre-consolidation shares. The consolidation had not been effected as of the date of this Quarterly Report, and share and per-share amounts in this Quarterly Report are presented on a pre-consolidation basis.
Vireo Growth reverse split. On June 5, 2026, Vireo Growth Inc. completed a 30-to-1 reverse split. The Company’s Vireo warrants now represent 333,333 warrants exercisable at $6.70 (CAD$9.51), and comparative amounts have been retroactively adjusted.
Results of Operations
Comparison of the Three and Nine Months Ended September 30, 2026 and 2025
Significant items contributing to the change in net income (loss) are summarized below.
Total Revenues
All revenue for the three and nine months ended September 30, 2026 and 2025 was earned from product sales of cannabis flower and pre-roll products. Total revenue for the three months ended September 30, 2026 was $11,019,038, an increase of $2,504,770 or approximately 29% as compared to $8,514,268 for the three months ended September 30, 2025. For the nine months ended September 30, 2026, total revenue was $31,448,533, an increase of $7,774,095 or approximately 33% as compared to $23,674,438 for the nine months ended September 30, 2025. The increase in revenue was driven primarily by continued growth at our New Jersey operations, which contributed $4,863,295 to revenue in the current quarter (as compared to $3,378,777 in the prior-year quarter) and $12,648,361 for the year-to-date period (as compared to $7,806,451 in the prior-year period), together with year-over-year growth in the Oregon and Michigan operations. Michigan revenue includes Michigan cannabis excise taxes, which took effect January 1, 2026, of approximately $346,678 and $1,094,920 for the three and nine months ended September 30, 2026, respectively; the corresponding expense is included in general and administrative expenses. Revenue decreased compared to the second quarter of 2026 ($11,273,837), mainly because of lower Oregon and Michigan sales, partially offset by higher New Jersey sales.
Cost of Revenues and Gross Profit
Cost of finished cannabis inventory sold for the three months ended September 30, 2026 was $5,536,034, an increase of $680,790 or approximately 14% as compared to $4,855,244 for the three months ended September 30, 2025. For the nine months ended September 30, 2026, cost of finished cannabis inventory sold was $16,637,918, an increase of $3,540,736 or approximately 27% as compared to $13,097,182 for the nine months ended September 30, 2025. Cost of revenues increased at a lower rate than revenue, reflecting a greater proportion of higher-margin New Jersey sales.
Gross profit for the three months ended September 30, 2026 was $5,483,004 (a gross margin of approximately 50%), an increase of $1,823,980 or approximately 50% as compared to $3,659,024 for the three months ended September 30, 2025 (a gross margin of approximately 43%). For the nine months ended September 30, 2026, gross profit was $14,810,615 (a gross margin of approximately 47%), an increase of $4,233,359 or approximately 40% as compared to $10,577,256 for the nine months ended September 30, 2025 (a gross margin of approximately 45%).
36
Operating Expenses
Total operating expenses for the three months ended September 30, 2026 were $5,749,913, an increase of $2,359,800 or approximately 70% as compared to $3,390,113 for the three months ended September 30, 2025. For the nine months ended September 30, 2026, total operating expenses were $14,141,213, an increase of $3,554,828 or approximately 34% as compared to $10,586,385 for the nine months ended September 30, 2025.
The increase for the three months ended September 30, 2026 was driven principally by higher general and administrative expenses ($5,332,245 for the three months ended September 30, 2026 as compared to $2,964,469 in the prior-year quarter). This reflects headcount and infrastructure additions to support growth and expansion activities, including pre-operational costs of the new production locations in Minnesota, New York and Illinois, and Michigan cannabis excise taxes. Share-based compensation expense was $328,455 (prior-year quarter – $314,951), and depreciation expense was $89,213 (prior-year quarter – $110,693).
The year-to-date increase was driven principally by higher general and administrative expenses ($13,262,652 for the nine months ended September 30, 2026 as compared to $8,175,095 for the prior-year period), for the same reasons. This was partially offset by lower share-based compensation expense ($632,536 for the nine months ended September 30, 2026 as compared to $2,087,686 for the prior-year period), reflecting the timing of restricted share unit and stock option vesting, and lower depreciation expense ($246,025 as compared to $323,604 for the prior-year period).
Other Income (Expense)
Total other income (expense) was an expense of $5,466,537 for the three months ended September 30, 2026 as compared to income of $1,807,626 for the three months ended September 30, 2025, and was an expense of $8,709,061 for the nine months ended September 30, 2026 as compared to income of $6,035,261 for the nine months ended September 30, 2025.
The year-over-year changes were driven principally by:
| ● | the $5,030,332 loss on the acquisition of the remaining interest in Rogue EBC recognized in the third quarter of 2026 (see “Recent Developments”); |
| ● | unrealized losses on the Vireo Growth warrant asset of $105,528 in the current quarter and $2,853,195 year-to-date, as compared to unrealized gains of $2,162,087 and $821,433, respectively, in the prior-year periods, reflecting the decline in Vireo Growth’s share price; and |
| ● | the absence in 2026 of the $5,859,744 realized gain on the derivative liability recognized in 2025 on the extinguishment of the convertible debentures. |
These were partially offset by unrealized gains on the interest rate swaps of $131,671 in the current quarter and $280,054 year-to-date (prior-year periods – losses of $24,242 and $51,896), an unrealized gain on the warrant liability of $369,103 year-to-date (current quarter – loss of $64,444), higher interest income of $46,264 in the current quarter and $192,807 year-to-date (as compared to $36,736 and $109,010, respectively), and a lower loss on the equity investment in Rogue EBC of $8,180 in the current quarter and $301,430 year-to-date (as compared to $75,733 and $344,153), as Rogue EBC was consolidated from July 14, 2026. Interest and accretion expense was $532,984 in the current quarter and $1,512,204 year-to-date (as compared to $410,925 and $1,101,649, respectively). The increase reflects the larger average outstanding balance under the Western Alliance Bank credit facility and interest on the Fridley tenant improvement allowance.
37
Income Tax Expense
Income tax expense was $3,154,693 for the three months ended September 30, 2026 as compared to $511,381 for the three months ended September 30, 2025. Income tax expense was $4,542,895 for the nine months ended September 30, 2026, as compared to $2,062,728 for the nine months ended September 30, 2025. The Company recorded income tax expense despite a pre-tax loss in 2026, resulting in effective tax rates of 55% and 57% for the three and nine months ended September 30, 2026, respectively. The effective tax rate for the three and nine months ended September 30, 2026 reflects the effect of IRC Section 280E on our income tax provision, the increase in our uncertain tax position liability, inclusive of interest and penalties, and the loss on acquisition of Rogue EBC, for which no tax benefit was recognized. As at September 30, 2026, the uncertain tax liability, inclusive of penalties and interest and net of net operating loss carry-forwards, was $12,094,117 (December 31, 2025 - $8,383,888) and is included in other non-current liabilities. The Company had deferred tax assets of $1,744,522 at September 30, 2026 (December 31, 2025 – $1,522,760) and has concluded that no valuation allowance is required. For further discussion, see Note 18 to the unaudited condensed consolidated financial statements.
Net Income (Loss)
Net loss for the three months ended September 30, 2026 was $8,888,139, as compared to net income of $1,565,156 for the three months ended September 30, 2025. For the nine months ended September 30, 2026, net loss was $12,582,554 as compared to net income of $3,963,404 for the nine months ended September 30, 2025. The net losses in 2026 include the $5,030,332 loss on the acquisition of Rogue EBC. Net loss attributable to shareholders was $9,078,320 for the current quarter and $13,473,373 year-to-date. Net income attributable to non-controlling interests was $1,279,574 and $1,980,212, respectively, and net loss attributable to the redeemable non-controlling interest was $1,089,393 for both periods. Net income attributable to the non-controlling interest in GRMA equals the 15% preferred return on the GRMA Units. GRNY’s net loss is attributed using the hypothetical liquidation at book value method and, because the holder of the GRNY Preferred Units contributed all of GRNY’s capital, was attributed entirely to the redeemable non-controlling interest. For further discussion, see Notes 3 and 23 to the unaudited condensed consolidated financial statements.
Segment Reporting
The Company operates in three reportable segments – Oregon, Michigan, and New Jersey – with general corporate and administrative expenses and the results of its Illinois, Minnesota and New York operations, which are being provisioned, included within “Corporate” to reconcile the reportable segments to the financial statements. The following summarizes performance by segment for the three and nine months ended September 30, 2026 and 2025:
For the three months ended September 30, 2026: net revenue of $3,132,868 (Oregon), $3,022,875 (Michigan), and $4,863,295 (New Jersey); gross profit of $795,906 (Oregon), $1,684,778 (Michigan), and $3,002,320 (New Jersey); and net income (loss) of $132,033 (Oregon), $759,563 (Michigan), $2,438,339 (New Jersey), and $(12,218,074) (Corporate).
For the three months ended September 30, 2025: net revenue of $2,598,413 (Oregon), $2,537,078 (Michigan), and $3,378,777 (New Jersey); gross profit of $587,794 (Oregon), $1,322,589 (Michigan), and $1,748,641 (New Jersey); and net income (loss) of $(48,725) (Oregon), $683,619 (Michigan), $1,146,738 (New Jersey), and $(216,476) (Corporate).
For the nine months ended September 30, 2026: net revenue of $9,641,175 (Oregon), $9,158,997 (Michigan), and $12,648,361 (New Jersey); gross profit of $2,556,276 (Oregon), $4,596,796 (Michigan), and $7,657,543 (New Jersey); and net income (loss) of $663,535 (Oregon), $1,374,907 (Michigan), $4,213,024 (New Jersey), and $(18,834,020) (Corporate). Michigan segment revenue includes approximately $1,094,920 of Michigan cannabis excise taxes.
38
For the nine months ended September 30, 2025: net revenue of $8,547,359 (Oregon), $7,320,628 (Michigan), and $7,806,451 (New Jersey); gross profit of $2,961,504 (Oregon), $3,472,102 (Michigan), and $4,143,650 (New Jersey); and net income (loss) of $1,086,684 (Oregon), $1,659,969 (Michigan), $2,707,534 (New Jersey), and $(1,490,783) (Corporate).
All revenue for the three and nine months ended September 30, 2026 and 2025 was earned in the United States. For the three and nine months ended September 30, 2026 and 2025, no customer represented more than 10% of the Company’s net revenue, and as at September 30, 2026 and December 31, 2025, no customer represented more than 10% of the Company’s accounts receivable.
Non-GAAP Financial Measures (EBITDA and Adjusted EBITDA)
In addition to financial measures presented in accordance with U.S. GAAP, management uses non-GAAP financial measures, including EBITDA and Adjusted EBITDA, to evaluate operating performance, for financial and operational decision-making, planning and forecasting purposes, and to compare results across accounting periods. EBITDA is defined as net income or loss before interest, taxes, depreciation and amortization, further adjusted to remove transaction costs, share-based compensation expense, accretion expense, gain or loss on derecognition of derivative liabilities, impairment of intangible assets, losses on acquisitions, and other non-cash items or items not representative of operational performance. Adjusted EBITDA is EBITDA further adjusted for the impact of significant or unusual transactions, including, where applicable, costs associated with business acquisitions and pre-opening operating costs of new production locations.
These non-GAAP financial measures do not have any defined meaning under U.S. GAAP and may not be comparable to similarly titled measures presented by other companies. They should be considered in addition to, and not as a substitute for, financial measures prepared in accordance with U.S. GAAP.
The following table provides a reconciliation of net income (loss), as reported, to EBITDA and Adjusted EBITDA (non-GAAP) for the three and nine months ended September 30, 2026 and 2025:
Adjusted EBITDA Reconciliation Table (Unaudited) (US$)
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net income (loss) | (8,888,139 | ) | 1,565,156 | (12,582,554 | ) | 3,963,404 | ||||||||||
| Add back amortization of property and equipment included in cost of sales | 659,253 | 895,472 | 2,236,290 | 1,987,906 | ||||||||||||
| Add back interest and accretion expense | 532,984 | 410,925 | 1,512,204 | 1,101,649 | ||||||||||||
| Add back amortization of property and equipment | 89,213 | 110,693 | 246,025 | 323,604 | ||||||||||||
| Add back income tax expense | 3,154,693 | 511,381 | 4,542,895 | 2,062,728 | ||||||||||||
| EBITDA | (4,451,996 | ) | 3,493,627 | (4,045,140 | ) | 9,439,291 | ||||||||||
| Add back share-based compensation | 328,455 | 314,951 | 632,536 | 2,087,686 | ||||||||||||
| Deduct gain on derivative liability | (131,671 | ) | 24,242 | (280,054 | ) | (5,807,848 | ) | |||||||||
| Deduct interest and other income (expense) | (143,260 | ) | (156,439 | ) | (338,943 | ) | (851,782 | ) | ||||||||
| Add back changes in FV on warrants asset and liability | 169,972 | (2,162,087 | ) | 2,484,092 | (821,433 | ) | ||||||||||
| Add back loss on acquisition of Rogue EBC | 5,030,332 | - | 5,030,332 | - | ||||||||||||
| Add back loss on equity investment in associate | 8,180 | 75,733 | 301,430 | 344,153 | ||||||||||||
| Deduct GAAP bad debt conversion adjustment | - | (79,000 | ) | - | (237,000 | ) | ||||||||||
| Add back Golden Harvests acquisition costs | - | - | - | 60,000 | ||||||||||||
| Add back pre-operational startup costs(1) | 1,761,194 | - | 2,408,356 | - | ||||||||||||
| Adjusted EBITDA | 2,571,206 | 1,511,027 | 6,192,609 | 4,213,067 | ||||||||||||
| (1) | During the three and nine months ended September 30, 2026, we incurred approximately $1,761,194 and $2,408,356, respectively, in pre-operational startup costs associated with the build-out of new production locations, including occupancy and pre-operational costs related to the Fridley, Minnesota production facility and the Hamptonburgh facility, offset by reimbursements from SEA Craft LLC. No such costs were incurred in the comparable 2025 periods. |
39
Liquidity and Capital Resources
Sources of Liquidity
Our ability to generate cash in the short term is based upon sales from production and financing proceeds, and in the long term is based upon sales from production (including production from investments to increase output), growth by business acquisitions, or a combination thereof. Investments to increase production or acquire businesses may require further financing. We generate operating cash flows from sales of cannabis products, the margins on which contribute to coverage of our other operating costs. Historically, we have raised financing through debt and equity, including, during 2026, the sale of preferred equity interests in our GRMA and GRNY subsidiaries. These funds have been, and are expected to continue to be, invested in the business to improve yields, fund operating costs, and support strategic expansion.
We are typically able to sell inventory shortly after it reaches finished goods, with sales primarily made on cash-on-delivery terms or with short net terms. Our ability to fund operations, to plan capital expenditures, and to plan acquisitions, depends on future operating performance and cash flows and the availability of capital by way of debt or equity investment in the Company, which are subject to prevailing economic conditions and financial, business, and other factors, some of which are beyond our control.
We believe that our cash on hand at September 30, 2026, projected cash flows from current and future anticipated sales of finished goods, the undrawn GRNY loan commitment, and net proceeds from current and anticipated financing activities, will be sufficient to meet our liquidity and capital resource requirements for the next twelve months from the date of issuance of this Quarterly Report on Form 10-Q, including our commitments in connection with the New York expansion.
Working Capital
At September 30, 2026 and December 31, 2025, our working capital was approximately $17,551,070 and $16,590,979, respectively, calculated as current assets less current liabilities (excluding the derivative liability and the warrant liabilities, in each case representing non-cash fair value items). Cash and cash equivalents were $16,602,268 at September 30, 2026 as compared to $11,371,834 at December 31, 2025. Total current assets were $30,740,946 at September 30, 2026 as compared to $22,178,714 at December 31, 2025. The increase reflects higher cash, and higher prepaid expenses and other current assets ($2,489,611 compared to $563,912), which include a $1,515,580 deposit paid toward the consideration for the proposed acquisition of PCNY.
Total current liabilities were $14,360,438 at September 30, 2026 as compared to $5,724,776 at December 31, 2025. The increase reflects:
| ● | higher accounts payable and accrued liabilities ($4,863,725 compared to $1,262,519), mainly from the start-up of the Minnesota and New York operations; |
| ● | a higher current portion of operating lease liabilities ($2,824,083 compared to $844,421), mainly from the Hamptonburgh facility lease; |
| ● | a higher current portion of business acquisition consideration payable ($1,468,315 compared to $455,844), including the deferred Rogue EBC consideration; |
| ● | a higher current portion of long-term debt ($3,011,112 compared to $2,576,228); |
| ● | the warrant liabilities of $1,170,562, reclassified to current liabilities effective January 1, 2026 in connection with the change in functional currency; and |
| ● | income tax payable of $725,453 at September 30, 2026 (December 31, 2025 – $296,018). |
40
We expect significant ongoing fluctuations in working capital over time as we continue to invest in expansion of cultivation capacity at ABCO Garden State, LLC and the build-out of operations in Illinois, Minnesota and New York. We have historically been able to meet commitments, modify debt maturities, and raise new financing as required to respond to changes in our liquidity position, although there is no guarantee we will be able to do so in the future.
Cash Flows
Cash and cash equivalents increased by $5,230,434 during the nine months ended September 30, 2026 to $16,602,268. This compares to an increase of $8,663,562 during the nine months ended September 30, 2025, from $4,917,708 at January 1, 2025 to $13,581,270 at September 30, 2025.
Operating Activities
Net cash provided by operating activities was $5,924,360 for the nine months ended September 30, 2026, as compared to net cash used in operating activities of $15,060 for the nine months ended September 30, 2025. The current-period result reflects $2,745,833 of tenant improvement allowance proceeds for the Fridley, Minnesota facility and approximately $4,465,705 of favorable changes in non-cash working capital, principally increases in the uncertain tax position liability ($3,710,229), accounts payable and accrued liabilities ($3,428,584) and income tax payable ($429,435), partially offset by increases in prepaid expenses ($1,787,699, including the deposit paid toward the consideration for the proposed acquisition of PCNY), accounts receivable ($986,692) and inventory ($328,152).
Investing Activities
Net cash used in investing activities was $12,065,101 for the nine months ended September 30, 2026, as compared to $2,339,779 for the nine months ended September 30, 2025. The current-period use was driven principally by $9,335,612 in property and equipment additions (as compared to $1,072,054 in the prior-year period), supporting the build-out of cultivation capacity at ABCO Garden State, LLC through the Grandview Phase II project and the Minnesota and Illinois expansion activities. It also included $1,984,419 in notes receivable advances (including $484,420 advanced to PCNY), $465,000 advanced on the purchase of the remaining Rogue EBC equity interest (partially offset by $35,879 of cash acquired on consolidation), a $200,000 security deposit, and $115,949 in payments of business acquisition consideration payable.
Financing Activities
Net cash provided by financing activities was $11,371,175 for the nine months ended September 30, 2026, as compared to $11,014,380 for the nine months ended September 30, 2025. Significant financing activities for the current period included:
| ● | $10,000,000 in proceeds from the issuance of the GRNY Preferred Units; |
| ● | net proceeds of $2,985,000 from the sale of a 20% non-controlling interest in GRMA (gross proceeds of $3,000,000 less $15,000 of issuance costs); |
| ● | $500,000 in proceeds from long-term debt and $21,839 from stock option exercises; |
| ● | $1,507,273 in repayment of long-term debt and $17,618 in repayment of finance leases; and |
| ● | $610,773 of distributions to non-controlling interests in subsidiaries. |
41
Indebtedness
Our long-term debt and related obligations consist primarily of:
| ● | a senior secured credit facility (the “Credit Facility”) with Bridge Bank, a division of Western Alliance Bank (“WAB”), entered into on March 27, 2025 and amended and upsized on September 9, 2025, providing for maximum borrowings of up to $12,000,000 (fully drawn), with a four-year term and bearing interest at the greater of (a) the Secured Overnight Financing Rate plus 4.9% and (b) 9.0% per annum; |
| ● | a secured note of GRU Properties, LLC dated January 12, 2024 in the principal amount of $1,285,000, maturing December 1, 2027; |
| ● | secured promissory notes of ABCO Garden State, LLC issued from time to time under a $1,100,000 advance facility with PMW LLC, bearing interest at 16% per annum; and |
| ● | a $450,000 convertible promissory note of ABCO dated October 17, 2024, bearing interest at 15% per annum and maturing October 17, 2027 (subject to extensions tied to the receipt of approval by the New Jersey Cannabis Regulatory Commission of GR Unlimited’s option to acquire equity of Nile of NJ LLC). |
On May 14, 2025 and September 15, 2025, we entered into interest rate swap agreements with respect to the $7,000,000 and $5,000,000 tranches of the Credit Facility, which effectively fix the interest rate on those tranches at 8.07% and 7.53% per annum, respectively. At September 30, 2026, the interest rate swaps were a net derivative asset of $143,013 (December 31, 2025 – net derivative liability of $137,041).
In addition, GRNY has an undrawn commitment of up to $5,000,000 from the holder of the GRNY Preferred Units, available until August 20, 2027 (see “Recent Developments” and Note 24 to the unaudited condensed consolidated financial statements). The Fridley tenant improvement allowance of $2,750,000 is accounted for as a lease incentive within operating lease liabilities.
The Credit Facility contains negative covenants requiring that we maintain a fixed charge coverage ratio (as defined therein) of not less than 1.5 to 1.0 and a leverage ratio (as defined therein) of no more than 2.0 to 1.0, in each case as of the last day of any fiscal quarter. As of September 30, 2026, the Company believes it was in compliance with all financial covenants under the Credit Facility.
For a complete description of our long-term debt, derivative liability, and consideration payable on business acquisitions, refer to Notes 13, 14, 15, and 16 to the audited consolidated financial statements included in our Annual Report, and to Notes 12 and 13 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
Contractual Obligations and Commitments
Set out below are undiscounted minimum future lease payments after September 30, 2026 for the Company’s operating and finance leases.
| ● | Operating leases: total payments of approximately $67,717,556 ($1,364,388 for the remainder of 2026, $9,599,049 in 2027, $10,565,387 in 2028, $12,536,730 in 2029, $9,125,371 in 2030, and $24,526,631 thereafter), less unamortized interest of approximately $25,522,241, for a total operating lease liability of approximately $42,195,315. |
| ● | Finance leases: total payments of approximately $4,997,624 ($243,750 for the remainder of 2026, $553,874 in 2027, $480,000 in each of 2028, 2029 and 2030, and $2,760,000 thereafter), less unamortized interest of approximately $2,252,714, for a total finance lease liability of approximately $2,744,910. |
42
The increase from June 30, 2026 is mainly due to the Hamptonburgh facility lease, the Fridley tenant improvement allowance, and the Fridley HVAC equipment finance lease. For further discussion, see Note 11 to the unaudited condensed consolidated financial statements.
As of September 30, 2026, total long-term debt was approximately $11,768,758 (comprising a current portion of $3,011,112 and a non-current portion of $8,757,646), as compared to $12,733,162 at June 30, 2026. Total long-term debt payments are approximately $14,038,642 ($1,600,403 for the remainder of 2026, $3,699,307 in 2027, $2,825,805 in 2028, and $5,913,127 in 2029), less unamortized interest of approximately $2,269,884, resulting in a total long-term debt liability of approximately $11,768,758. For a complete description of the Company’s debt obligations, refer to Note 12 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
Other commitments at September 30, 2026 include:
| ● | deferred Rogue EBC consideration of $1,000,000 (undiscounted), payable in 2027; |
| ● | GRNY’s secured line of credit to PCNY of up to $9.0 million, of which $8.5 million was undrawn at September 30, 2026 and is advanced at GRNY’s sole discretion (on November 4, 2026, GRNY advanced an additional $1,000,000 to PCNY, reducing the undrawn amount to $7,500,000); and |
| ● | the ABCO Grandview Phase II and Phase III construction agreement with Blackwell, a related party, with estimated costs of approximately $1,430,000 and $1,527,000, respectively, including Blackwell’s fee (Note 24). |
Off-Balance Sheet Arrangements
As described under “Recent Developments” and in Note 25 to the unaudited condensed consolidated financial statements, at September 30, 2026 GRNY held variable interests in PCNY, an unconsolidated variable interest entity. GRNY’s maximum exposure to loss was $2,000,000, and the undrawn $8.5 million of the line of credit is excluded from that amount because GRNY has no unconditional obligation to make further advances. On November 4, 2026, GRNY advanced an additional $1,000,000 to PCNY, reducing the undrawn amount of the line of credit to $7,500,000. The Company and Grown Rogue Unlimited, LLC have also guaranteed GRNY’s obligations under the Hamptonburgh facility lease. Other than these arrangements, during the three and nine months ended September 30, 2026 and 2025, we did not have, nor do we currently have, any off-balance sheet arrangements as defined in the applicable rules of the SEC.
Critical Accounting Policies and Estimates
The preparation of our unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses, and the disclosure of contingent assets and liabilities at the date of the financial statements. Significant areas requiring estimation and judgment include:
| ● | the assessment of transactions as business combinations or asset acquisitions; |
| ● | the valuation and costing of inventory; |
| ● | the impairment of long-lived and indefinite-lived intangible assets; |
| ● | fair value measurements, including share-based compensation, derivative assets and liabilities, and warrant assets and liabilities; |
| ● | the recoverability and measurement of deferred tax assets and liabilities; |
43
| ● | the recognition and measurement of uncertain tax positions, including those arising under Section 280E of the Internal Revenue Code; |
| ● | the determination of lease terms and incremental borrowing rates; and |
| ● | the consolidation of entities in which we hold less than a majority of voting rights, or in which we hold variable interests, including the determination of whether we are the primary beneficiary of a variable interest entity. |
During the three months ended September 30, 2026, significant judgments were applied in the following areas:
| ● | the accounting for the acquisition of the remaining interest in Rogue EBC as an asset acquisition, including the fair value assessment of the assets acquired and the recognition of the related loss on acquisition (Note 4); |
| ● | the conclusion that GRNY was not the primary beneficiary of PCNY at September 30, 2026 (Note 25); and |
| ● | the attribution of GRNY’s net income or loss to the redeemable non-controlling interest using the hypothetical liquidation at book value method (Notes 3 and 23). |
Other than these items, there have been no material changes to our critical accounting policies and estimates from those disclosed under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in our Annual Report.
Recently Issued Accounting Pronouncements
For a discussion of recently issued and recently adopted accounting pronouncements and their expected impact, if any, on our consolidated financial statements, refer to Note 3 – Significant Accounting Policies in the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, and to Note 3 to the audited consolidated financial statements included in our Annual Report.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Not applicable.
ITEM 4. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision of and with the participation of the Company’s management, including our chief executive officer (“CEO”) and chief financial officer (“CFO”), of the effectiveness of the design and operations of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based on that evaluation, the CEO and the CFO have concluded that as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company’s disclosure controls and procedures were effective as of September 30, 2026.
Changes to Internal Controls and Procedures over Financial Reporting
Management, with the participation of the CEO and CFO, concluded that there were no changes in our internal control over financial reporting during the three months ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
44
PART II. OTHER INFORMATION.
Item 1. Legal Proceedings
On September 22, 2022, the SEC instituted administrative proceedings against the Company under Section 12(j) of the Exchange Act, alleging violations of the Exchange Act for failing to timely file its periodic reports. On June 22, 2026, the matter was dismissed.
There are no pending legal proceedings to which we or our subsidiaries are a party or of which any of our property or assets is subject. There are no legal proceedings to which any of the directors, officers or affiliates or any associate of any such directors, officers or affiliates of either our company or our subsidiary is a party or has a material interest adverse to us.
We may, from time to time, become involved in disputes and proceedings arising in the ordinary course of business. In addition, as a public company, we are also potentially susceptible to litigation, such as claims asserting violations of securities laws. Any such claims, with or without merit, if not resolved, could be time-consuming and result in costly litigation. There can be no assurance that an adverse result in any future proceeding would not have a potentially material adverse effect on our business, results of operations, and financial condition.
Item 1A. Risk Factors
Except as set forth below, there have been no material changes to the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the year ended December 31, 2025.
Our pending acquisition of PCNY may not be completed, and our arrangements with PCNY expose us to financial and accounting risks we do not control.
Grown Rogue New York, LLC (“GRNY”) is negotiating definitive agreements to acquire the licenses and select assets of PharmaCann of New York, LLC (“PCNY”). Any acquisition will require New York regulatory approval. Pending the acquisition, GRNY provides support services to PCNY, lends to PCNY under a secured line of credit, has paid a deposit toward the acquisition consideration, and subleases the Hamptonburgh facility to PCNY while remaining liable under the master lease. PCNY retains control of its licenses and operations. At September 30, 2026, our maximum exposure to loss was $2,000,000, and GRNY advanced an additional $1,000,000 on November 4, 2026. If the acquisition is not completed, we could lose these amounts and remain liable under the lease. Signing definitive agreements may also require us to consolidate PCNY. Our financial statements would then include PCNY’s results, which depend on accounting policies, close timelines and internal controls we do not currently control.
Our Illinois operations depend on SEA Craft’s license, and our acquisition of an interest in SEA Craft remains subject to regulatory approval.
Our operations in Dwight, Illinois depend on the license of SEA Craft, LLC (“SEA Craft”). 49% acquisition of SEA Craft has not yet received regulatory approval. If approval is denied or conditioned, regulators find that our arrangements give us unapproved control of SEA Craft, or SEA Craft loses its license, we could lose our investment, remain liable under the guarantee and record impairment charges.
45
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended September 30, 2026, there were no unregistered sales of equity securities that were not previously reported in a Current Report on Form 8-K. The issuance of the GRNY Preferred Units, which are convertible into SV Shares of the Company, and the Company’s agreement to issue 300,000 SV Shares and warrants in connection with the GRNY loan commitment, were reported in Item 3.02 of the Company’s Current Report on Form 8-K filed on August 25, 2026.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended September 30, 2026, no director or Section 16 officer of the Company
46
ITEM 6. EXHIBITS
EXHIBIT INDEX
47
| * | Filed herewith. |
48
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GROWN ROGUE INTERNATIONAL INC. | ||
| /s/ Obie Strickler | ||
| By: | Obie Strickler, President and Chief Executive Officer and Director (Principal Executive Officer) |
|
| Dated: | November 13, 2026 | |
| /s/ Andrew Marchington | ||
| By: | Andrew Marchington, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
|
| Dated: | November 13, 2026 | |
49